A. Neubert

Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors.

A. D'arcy, M. Mogi, C. Wiesmann, 2020, ACS medicinal chemistry letters.

Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides.

B. Hubbard, Erik C. Rocheford, Tara L Mullarkey, 2012, ACS medicinal chemistry letters.

Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme.

A. Jeng, P. Savage, E. Wallace, 1998, Journal of medicinal chemistry.

Synthesis and structure-activity relationships of oxamic acid and acetic acid derivatives related to L-thyronine.

A. Engle, J. Wasvary, J. Stanton, 1995, Journal of medicinal chemistry.

2-Arylpyrazolo[4,3-c]quinolin-3-ones: novel agonist, partial agonist, and antagonist of benzodiazepines.

N Yokoyama, B Ritter, A D Neubert, 1982, Journal of medicinal chemistry.

2-ARYLPYRAZOLO(4,3-C)QUINOLIN-3-ONES: A NOVEL AGONIST, A PARTIAL AGONIST AND AN ANTAGONIST OF BENZODIAZEPINES

N. Yokoyama, B. Ritter, A. D. Neubert, 1982 .

Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans.

T. Gilmore, V. Tedesco, B. Hubbard, 2017, Journal of medicinal chemistry.

Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.

A. Jeng, P. Kukkola, J. Stanton, 2005, Journal of medicinal chemistry.